GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)
Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide
Pill with imprint GSI 255 is Gray, Capsule-shape and has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..
Odefsey is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 255
Odefsey
- Generic Name
- emtricitabine/rilpivirine/tenofovir alafenamide
- Imprint
- GSI 255
- Strength
- emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
- Color
- Gray
- Size
- 15.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- Inactive Ingredients
-
lactose monohydrate, microcrystalline cellulose, polysorbate 20, croscarmellose sodium, magnesium stearate, water, titanium dioxide, magnesium silicate, ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 61958-2101 | Gilead Sciences, Inc. |
| 54569-6645 | A-S Medication Solutions, LLC (repackager) |
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 6 Reviews
- Drug class: antiviral combinations
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
